Drug

2-(6-(2-(3,5-dichloro-4-pyridyl)acetyl)-2,3-dimethoxyphenoxy)-N-propylacetamide clinical trials

Also written LEO 29102.

studies test it: 8
open now: 0
in phase 3: 0
first study started: 2009

How studies write it

Studies that test it under each name

Studies by the year they started

8 studies that test it; most in 2009 (5)

Studies that test 2-(6-(2-(3,5-dichloro-4-pyridyl)acetyl)-2,3-dimethoxyphenoxy)-N-propylacetamide, by start year
Year	Studies
2009	5
2011	3

By phase

A phase 1/2 study counts in both.

Phase 1: 6
Phase 2: 2

What it is tested for

Each study’s main condition, where its own words name it.

Dermatitis, Atopic: 4
Psoriasis: 2
Dermatitis: 2

Who runs them

Industry 8 · Other 0

LEO Pharma (8)

Often tested with

Tested in the same studies.

Betamethasone dipropionate (2) · Betamethasone (2) · Calcipotriene (2)

Studies

Open first, then newest update. How each study uses 2-(6-(2-(3,5-dichloro-4-pyridyl)acetyl)-2,3-dimethoxyphenoxy)-N-propylacetamide is read from its arms, and is right about nine times in ten.

2-(6-(2-(3,5-dichloro-4-pyridyl)acetyl)-2,3-dimethoxyphenoxy)-N-propylacetamide clinical trials

How studies write it

Name

Development codes

Combined with it in one product